765 related articles for article (PubMed ID: 22886119)
1. Impact of pharmacovigilance on adverse drug reactions reporting in hospitalized internal medicine patients at Saudi Arabian teaching hospital.
Khan LM; Al-Harthi SE; Saadah OI; Al-Amoudi AB; Sulaiman MI; Ibrahim IM
Saudi Med J; 2012 Aug; 33(8):863-8. PubMed ID: 22886119
[TBL] [Abstract][Full Text] [Related]
2. Adverse drug reactions in hospitalized pediatric patients of Saudi Arabian University Hospital and impact of pharmacovigilance in reporting ADR.
Khan LM; Al-Harthi SE; Saadah OI
Saudi Pharm J; 2013 Jul; 21(3):261-6. PubMed ID: 23960842
[TBL] [Abstract][Full Text] [Related]
3. Incidence of hospital admissions due to adverse drug reactions in France: the EMIR study.
Bénard-Laribière A; Miremont-Salamé G; Pérault-Pochat MC; Noize P; Haramburu F;
Fundam Clin Pharmacol; 2015 Feb; 29(1):106-11. PubMed ID: 24990220
[TBL] [Abstract][Full Text] [Related]
4. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal.
Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J
Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive 4-year survey of adverse drug reactions using a network-based hospital system.
Chen CJ; Cheng CF; Lin HY; Hung SP; Chen WC; Lin MS
J Clin Pharm Ther; 2012 Dec; 37(6):647-51. PubMed ID: 22646235
[TBL] [Abstract][Full Text] [Related]
6. Adverse drug reaction monitoring: support for pharmacovigilance at a tertiary care hospital in Northern Brazil.
Lobo MG; Pinheiro SM; Castro JG; Momenté VG; Pranchevicius MC
BMC Pharmacol Toxicol; 2013 Jan; 14():5. PubMed ID: 23298396
[TBL] [Abstract][Full Text] [Related]
7. Online reporting of adverse drug reactions: a study from a French regional pharmacovigilance center.
Abadie D; Chebane L; Bert M; Durrieu G; Montastruc JL
Therapie; 2014; 69(5):395-400. PubMed ID: 25269141
[TBL] [Abstract][Full Text] [Related]
8. Drug interactions between antihypertensive drugs and non-steroidal anti-inflammatory agents: a descriptive study using the French Pharmacovigilance database.
Fournier JP; Sommet A; Durrieu G; Poutrain JC; Lapeyre-Mestre M; Montastruc JL;
Fundam Clin Pharmacol; 2014 Apr; 28(2):230-5. PubMed ID: 23190210
[TBL] [Abstract][Full Text] [Related]
9. Detection of adverse drug reactions through the minimum basic data set.
Salmerón-García A; Cabeza Barrera J; Vergara Pavón MJ; Román Márquez E; Cortés de Miguel S; Vallejo-Rodríguez I; Raya García S; Casado Fernández E
Pharm World Sci; 2010 Jun; 32(3):322-8. PubMed ID: 20213432
[TBL] [Abstract][Full Text] [Related]
10. [Retrospective analysis of adverse cutaneous drug reactions in patients hospitalized in Department of Dermatology and Venereology of Pomeranian Medical University in 1996-2006].
Kacalak-Rzepka A; Klimowicz A; Bielecka-Grzela S; Załuga E; Maleszka R; Fabiańczyk H
Ann Acad Med Stetin; 2008; 54(2):52-8. PubMed ID: 19374232
[TBL] [Abstract][Full Text] [Related]
11. Healthcare professionals' awareness and knowledge of adverse drug reactions and pharmacovigilance.
Almandil NB
Saudi Med J; 2016 Dec; 37(12):1359-1364. PubMed ID: 27874152
[TBL] [Abstract][Full Text] [Related]
12. [A study of incidence and clinical characteristics of adverse drug reactions in hospitalized patients.].
Esteban Jiménez Ó; Navarro Pemán C; González Rubio F; Lanuza Giménez FJ; Montesa Lou C
Rev Esp Salud Publica; 2017 Dec; 91():. PubMed ID: 29269726
[TBL] [Abstract][Full Text] [Related]
13. Frequency, types, severity, preventability and costs of Adverse Drug Reactions at a tertiary care hospital.
Geer MI; Koul PA; Tanki SA; Shah MY
J Pharmacol Toxicol Methods; 2016; 81():323-34. PubMed ID: 27109493
[TBL] [Abstract][Full Text] [Related]
14. Developing an adverse drug reaction reporting system at a teaching hospital.
Baniasadi S; Fahimi F; Shalviri G
Basic Clin Pharmacol Toxicol; 2008 Apr; 102(4):408-11. PubMed ID: 18312492
[TBL] [Abstract][Full Text] [Related]
15. Adverse drug reactions experience in a teaching hospital in Jordan.
Alsbou M; Alzubiedi S; Alzobi H; Samhadanah NA; Alsaraireh Y; Alrawashdeh O; Aqel A; Al-Salem K
Int J Clin Pharm; 2015 Dec; 37(6):1188-93. PubMed ID: 26286340
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of adverse reactions and pharmacovigilance research to parenterally administered shuxuening].
Yang W; Xiang YY; Xie YM; Shen H
Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):3013-8. PubMed ID: 24471322
[TBL] [Abstract][Full Text] [Related]
17. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital.
Jose J; Rao PG
Pharmacol Res; 2006 Sep; 54(3):226-33. PubMed ID: 16781163
[TBL] [Abstract][Full Text] [Related]
18. Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India.
Tandon VR; Mahajan V; Khajuria V; Gillani Z
Indian J Pharmacol; 2015; 47(1):65-71. PubMed ID: 25821314
[TBL] [Abstract][Full Text] [Related]
19. Adverse Drug Reactions in Hospitalized Pediatric Patients: A Prospective Observational Study.
Kurian J; Mathew J; Sowjanya K; Chaitanya KR; Ramesh M; Sebastian J; Narayanappa D
Indian J Pediatr; 2016 May; 83(5):414-9. PubMed ID: 26916890
[TBL] [Abstract][Full Text] [Related]
20. Knowledge, Practice and Attitudes Toward Pharmacovigilance and Adverse Drug Reactions Reporting Process Among Health Care Providers in Dammam, Saudi Arabia.
Ali MD; Hassan YA; Ahmad A; Alaqel O; Al-Harbi H; Al-Suhaimi NM
Curr Drug Saf; 2018; 13(1):21-25. PubMed ID: 29256354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]